Lynda Williams
Deputy Bureau Chief at medwireNews
Personal account - medical journalist who likes Scouting, sailing, kayaking and reading. She/Her. AKA Zebra and Osprey.
Articles
-
1 week ago |
medwirenews.com | Lynda Williams |Lucy Piper
By Lynda Williams, medwireNews ReportermedwireNews: For patients with active cancer and venous thromboembolism, a reduced dose of apixaban is noninferior to the standard dose for preventing recurrent thromboembolic episodes and significantly reduces the risk of clinically relevant bleeding, report the API-CAT investigators. This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.
-
2 weeks ago |
medwirenews.com | Lynda Williams |Lucy Piper
By Lynda Williams, medwireNews ReportermedwireNews: Children who survive for at least 5 years after treatment for cancer are 2.7 times more likely to develop one of eight aging-related chronic health conditions before the age of 65 years than members of the general population, US researchers suggest. This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.
-
2 weeks ago |
nuclear-news.net | Lynda Williams |Christina MacPherson
Nuclear Threat Beneath The Seas this development will not enhance Hawai‘i’s security; instead, it will place residents, ecosystems, and future generations in direct danger by turning the islands into a priority target in any potential nuclear conflict. Housing nuclear submarines does not enhance security—it increases risk.
-
2 weeks ago |
antinuclear.net | Lynda Williams |Christina MacPherson
Nuclear Threat Beneath The Seas this development will not enhance Hawai‘i’s security; instead, it will place residents, ecosystems, and future generations in direct danger by turning the islands into a priority target in any potential nuclear conflict. Housing nuclear submarines does not enhance security—it increases risk.
-
3 weeks ago |
medwirenews.com | Lynda Williams |Lucy Piper
By Lynda Williams, medwireNews ReportermedwireNews: Research indicates that women with triple-negative breast cancer might benefit from low-dose tamoxifen to reduce the risk of recurrent or new primary disease. This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France. Read the full story on the L’Institut Servier websiteImage credit: © Crystal light / Stock.adobe.com
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 1K
- Tweets
- 55K
- DMs Open
- No
RT @SheldrickTrust: NEW BABY! Lenana has just introduced us to her second son, Laki. Nearly two months had passed since Lenana's last visit…
RT @sarasheridan: Today's short thread - wicked historical women, because not everybody's granny was a saint, right? 1st up, the Duchess of…
RT @MatthewCappucci: Bay Area: you have 20 minutes before possible #tsunami arrives. We don't know yet IF a tsunami is occurring. The sid…
